Clinical and Health Care Resource Use Outcomes Associated With Resistance to Antiretroviral Therapy Among Veterans With HIV
In this real-world analysis, PWH with detectable resistance had lower CD4 counts, more frequent hospitalizations and opportunistic infections, greater economic costs, and increased discontinuation of ART.
Authors
- Phyllis C. Tien
- Michelle L. D’Antoni (ORCID: https://orcid.org/0009-0004-5395-7022)
- Mary J. Christoph (ORCID: https://orcid.org/0000-0001-8769-9931)
- Tammy H. Cummings (ORCID: https://orcid.org/0000-0001-7978-7157)
- Woodie Zachry
- Joseph Magagnoli (ORCID: https://orcid.org/0000-0002-8568-0097)
- Chase R. Williams
- Amy Weinberg (ORCID: https://orcid.org/0000-0001-8464-8362)
- S. Scott Sutton (ORCID: https://orcid.org/0000-0002-3889-6178)
- Cassidy Trom
- Uche Mordi
Institutions
- San Francisco VA Medical Center (US)
- University of South Carolina (US)
- Columbia VA Health Care System (US)
- Gilead Sciences (United States) (US)
- Gilead Sciences (Australia) (AU)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1093/ofid/ofaf340
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00